Literature DB >> 16390946

Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.

Caroline Besson1, Corinne Amiel, Catherine Le-Pendeven, Pauline Brice, Christophe Fermé, Patrice Carde, Olivier Hermine, Martine Raphael, Laurent Abel, Jean-Claude Nicolas.   

Abstract

Markers of Epstein-Barr virus (EBV) infection include measures of specific serological titers and of viral load (VLo) in peripheral blood mononuclear cells. Few studies have investigated the correlation between these two phenotypes. Here, we found that there was no correlation between VLo and either anti-EBV nuclear antigen type 1 or anti-early antigen immunoglobulin G (IgG) titer but that anti-viral capsid antigen (VCA) IgG titer increased with VLo in peripheral blood mononuclear cells in patients with Hodgkin's lymphoma (P = 3.10(-3)). A similar pattern was observed in healthy first-degree relatives (parents and siblings) of patients (P = 6.10(-4)). Our results indicate that anti-VCA IgG titers and EBV VLo are specifically correlated EBV phenotypes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16390946      PMCID： PMC1351946          DOI： 10.1128/JCM.44.1.47-50.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

2.  Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.

Authors:  Gulfaraz Khan; Annette Lake; Lesley Shield; June Freeland; Linda Andrew; Freda E Alexander; Robert Jackson; Penelope R A Taylor; Elizabeth A B McCruden; Ruth F Jarrett
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

3.  Is EBV persistence in vivo a model for B cell homeostasis?

Authors:  G Khan; E M Miyashita; B Yang; G J Babcock; D A Thorley-Lawson
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

4.  Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis.

Authors:  C A Horwitz; W Henle; G Henle; H Rudnick; E Latts
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

5.  Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections.

Authors:  Karen Brengel-Pesce; Patrice Morand; Anne Schmuck; Marie-Josette Bourgeat; Marlyse Buisson; Gérard Barguès; Makhlouf Bouzid; Jean-Marie Seigneurin
Journal:  J Med Virol       Date:  2002-03       Impact factor: 2.327

6.  Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  T C Wu; R B Mann; P Charache; S D Hayward; S Staal; B C Lambe; R F Ambinder
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

7.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.

Authors:  N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

Review 8.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

9.  Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.

Authors:  Susanne Maurmann; Lutz Fricke; Hans-Joachim Wagner; Peter Schlenke; Holger Hennig; Jürgen Steinhoff; Wolfram J Jabs
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

Authors:  S A Riddler; M C Breinig; J L McKnight
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113
View more
  14 in total

1.  Childhood environments and cytomegalovirus serostatus and reactivation in adults.

Authors:  Denise Janicki-Deverts; Sheldon Cohen; William J Doyle; Anna L Marsland; Jos Bosch
Journal:  Brain Behav Immun       Date:  2014-03-25       Impact factor: 7.217

2.  Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.

Authors:  David Eric Ouedraogo; Alain Makinson; Nils Kuster; Nicolas Nagot; Pierre-Alain Rubbo; Karine Bollore; Vincent Foulongne; Guillaume Cartron; Daniel Olive; Jacques Reynes; Jean-Pierre Vendrell; Edouard Tuaillon
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

3.  EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Po-Wen Chen; Wen-Yi Luo; Te-Huei Yeh; Hsei-Wei Wang; Chi-Ju Chen; Ching-Hwa Tsai
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

4.  Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye.

Authors:  Meav-Lang J Lay; Robyn M Lucas; Mala Ratnamohan; Janette Taylor; Anne-Louise Ponsonby; Dominic E Dwyer
Journal:  Virol J       Date:  2010-09-22       Impact factor: 4.099

5.  Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer.

Authors:  Diana V Pastrana; Ulrike Wieland; Steffi Silling; Christopher B Buck; Herbert Pfister
Journal:  Med Microbiol Immunol       Date:  2011-05-26       Impact factor: 3.402

6.  Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.

Authors:  Vincent Pedergnana; Laurène Syx; Aurélie Cobat; Julien Guergnon; Pauline Brice; Christophe Fermé; Patrice Carde; Olivier Hermine; Catherine Le-Pendeven; Corinne Amiel; Yassine Taoufik; Alexandre Alcaïs; Ioannis Theodorou; Caroline Besson; Laurent Abel
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

7.  Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.

Authors:  Corinne Miceli-Richard; Nicolas Gestermann; Corinne Amiel; Jérémie Sellam; Marc Ittah; Stephan Pavy; Alejandra Urrutia; Isabelle Girauld; Guislaine Carcelain; Alain Venet; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-05-26       Impact factor: 5.156

8.  Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis.

Authors:  Eric Jeziorski; Brigitte Senechal; Thierry Jo Molina; Francis Devez; Marianne Leruez-Ville; Patrice Morand; Christophe Glorion; Ludovic Mansuy; Joel Gaudelus; Marianne Debre; Francis Jaubert; Jean-Marie Seigneurin; Caroline Thomas; Irene Joab; Jean Donadieu; Frederic Geissmann
Journal:  PLoS One       Date:  2008-09-23       Impact factor: 3.240

9.  Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.

Authors:  Caroline Besson; Sophie Roetynck; Fionnuala Williams; Laurent Orsi; Corinne Amiel; Catherine Lependeven; Guillemette Antoni; Olivier Hermine; Pauline Brice; Christophe Ferme; Patrice Carde; Danielle Canioni; Josette Brière; Martine Raphael; Jean-Claude Nicolas; Jacqueline Clavel; Derek Middleton; Eric Vivier; Laurent Abel
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240

10.  The role of the immune response in merkel cell carcinoma.

Authors:  Pierre L Triozzi; Anthony P Fernandez
Journal:  Cancers (Basel)       Date:  2013-02-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.